Neovascular Glaucoma
Showing 1 - 25 of 2,113
Aflibercept Injection in Japanese Neovascular Glaucoma (NVG)
Recruiting
- Neovascular Glaucoma
- Aflibercept (Eylea, BAY86-5321)
-
Multiple Locations, JapanMany locations
Aug 17, 2022
Neovascular Glaucoma Trial in Aurora (Aflibercept)
Completed
- Neovascular Glaucoma
-
Aurora, ColoradoRocky Mountain Lions Eye Institute
Feb 16, 2022
Neovascular Glaucoma, Neovascularization Trial in Guangzhou (4mg/ml KDR2-2 suspension eyedrop, 16mg/ml KDR2-2 suspension
Recruiting
- Neovascular Glaucoma
- Neovascularization
- 4mg/ml KDR2-2 suspension eyedrop
- 16mg/ml KDR2-2 suspension eyedrop
-
Guangzhou, Guangdong, ChinaZhongshan Ophthalmic Center
Jan 4, 2022
Neovascular Glaucoma, Proliferative Diabetic Retinopathy Trial (anti-VEGF)
Not yet recruiting
- Neovascular Glaucoma
- Proliferative Diabetic Retinopathy
- (no location specified)
Dec 13, 2021
Glaucoma, Neovascular Trial in Bangkok (intravitreal ranibizumab, Trabeculectomy with mitomycinC)
Completed
- Glaucoma, Neovascular
- intravitreal ranibizumab
- Trabeculectomy with mitomycinC
-
Bangkok, ThailandNaris Kitnarong
Jul 12, 2021
Glaucoma, Primary Open Angle Glaucoma, Secondary Glaucoma Trial in Worldwide (drug, other, procedure)
Glaucoma, Neovascular, Vascular Endothelial Growth Factor Overexpression Trial in Hat-yai (Intracameral injection, Intravitreal
Recruiting
- Glaucoma, Neovascular
- Vascular Endothelial Growth Factor Overexpression
- Intracameral injection
- Intravitreal injection
-
Hat-yai, Songkhla, ThailandGlaucoma unit , Department of Ophthalmology Faculty of Medicine
Feb 3, 2022
Intraocular Pressure, Neovascular Glaucoma, Vascular Endothelial Growth Factor Overexpression Trial in Bangkoknoi (Aflibercept
Completed
- Intraocular Pressure
- +3 more
- Aflibercept Ophthalmic
-
Bangkoknoi, Bangkok, ThailandNaris Kitnarong
Jul 11, 2021
Glaucoma, Glaucoma Eye, Glaucoma, Open-Angle Trial (Micropulse Transscleral laser therapy)
Not yet recruiting
- Glaucoma
- +7 more
- Micropulse Transscleral laser therapy
- (no location specified)
Nov 14, 2022
Glaucoma, Glaucoma, Open-Angle, Glaucoma, Neovascular Trial in Montréal (MicroPulse® P3 Glaucoma Device (MP3))
Completed
- Glaucoma
- +6 more
- MicroPulse® P3 Glaucoma Device (MP3)
-
Montréal, Quebec, CanadaCentre Hospitalier de l'Université de Montréal (CHUM)
Sep 13, 2021
Glaucoma, New Onset Glaucoma, Neovascular Glaucoma Trial (Ranibizumab (Lucentis))
Withdrawn
- Glaucoma
- +3 more
- Ranibizumab (Lucentis)
- (no location specified)
Feb 13, 2020
IOP Decreased, Visual Impairment Trial in Minya (Procedure)
Completed
- IOP Decreased
- Visual Impairment
- Procedure
-
Minya, EgyptMinia University
Jan 10, 2020
Glaucoma, Neovascular Trial in Japan (Aflibercept (EYLEA, BAY86-5321), Topical IOP-lowering drugs)
Completed
- Glaucoma, Neovascular
- Aflibercept (EYLEA, BAY86-5321)
- Topical IOP-lowering drugs
-
Yoshida, Fukui, Japan
- +6 more
Feb 18, 2020
Glaucoma, Intraocular Pressure Trial in Hat Yai (The pops-titration group, The slow-coagulation group)
Completed
- Glaucoma
- Intraocular Pressure
- The pops-titration group
- The slow-coagulation group
-
Hat Yai, Songkhla, ThailandOphthalmology Department, Prince of Songkla University
Mar 31, 2020
Glaucoma, Open-Angle, Glaucoma Secondary, Glaucoma, Neovascular Trial (Ahmed Glaucoma Valve surgery)
Completed
- Glaucoma, Open-Angle
- +2 more
- Ahmed Glaucoma Valve surgery
- (no location specified)
Dec 30, 2019
Glaucoma, Open-Angle, Glaucoma Secondary, Glaucoma, Neovascular Trial (glaucoma implant procedure (Baerveldt), glaucoma implant
Completed
- Glaucoma, Open-Angle
- +3 more
- glaucoma implant procedure (Baerveldt)
- glaucoma implant procedure (Ahmed)
- (no location specified)
Dec 31, 2019
Glaucoma Trial in Vienna (Pilocarpine)
Recruiting
- Glaucoma
-
Vienna, AustriaDepartment of Clinical Pharmacology, Medical University of Vienn
Apr 6, 2022
Proliferative Diabetic Retinopathy Trial in Beijing (preoperative group and intraoperative group)
Completed
- Proliferative Diabetic Retinopathy
- preoperative group and intraoperative group
-
Beijing, Beijing, ChinaPeople's Hospital of Peking University
Jun 1, 2022
Eye Diseases Trial in Guangzhou
Recruiting
- Eye Diseases
-
Guangzhou, Guangdong, ChinaZhongshan Ophthalmic Center, Sun Yat-sen University
Apr 29, 2023
Refractory Glaucoma Trial (360 degrees subthreshold diode laser cyclophotocoagulation, 180 degrees subthreshold diode laser
Not yet recruiting
- Refractory Glaucoma
- 360 degrees subthreshold diode laser cyclophotocoagulation
- 180 degrees subthreshold diode laser cyclophotocoagulation
- (no location specified)
Feb 5, 2022
Diabetic Retinopathy, Diabetic Macular Edema, Age-Related Macular Degeneration Trial in France (Eye Fundus Double Capture for
Not yet recruiting
- Diabetic Retinopathy
- +4 more
- Eye Fundus Double Capture for Eye Diseases Screening with OphtAI Medical Device
-
Brest, France
- +7 more
Feb 21, 2023
Risk Prediction Model for Long-term Low Vision After Vitrectomy
Recruiting
- Proliferative Diabetic Retinopathy
- +2 more
-
Tianjin, Tianjin, ChinaTianjin medical university eye hosipital
Nov 28, 2022
Glaucoma, Corneal Transplantation, Inflammation Trial in Montréal (Sampling of tears, Sampling of aqueous humor)
Recruiting
- Glaucoma
- +2 more
- Sampling of tears
- Sampling of aqueous humor
-
Montréal, Quebec, CanadaCentre Hospitalier de l'Université de Montréal (CHUM)
Jul 4, 2022
Age-Related Macular Degeneration Trial in Hong Kong (Brolucizumab, Aflibercept)
Recruiting
- Age-Related Macular Degeneration
-
Hong Kong, Hong KongGrantham Hospital
Jan 25, 2023
Proliferative Diabetic Retinopathy Trial in Beijing (preoperative intravitreal injections of ranibizumab or conbercept)
Completed
- Proliferative Diabetic Retinopathy
- preoperative intravitreal injections of ranibizumab or conbercept
-
Beijing, Beijing, ChinaPeking University People's Hospital
Jun 7, 2022